↓ Skip to main content

Dove Medical Press

Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse?

Overview of attention for article published in Patient preference and adherence, April 2011
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
41 Mendeley
Title
Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse?
Published in
Patient preference and adherence, April 2011
DOI 10.2147/ppa.s17363
Pubmed ID
Authors

John D Piette, Ann Marie Rosland, Maria J Silveira, Rodney Hayward, Colleen A McHorney

Abstract

A national internet survey was conducted between March and April 2009 among 27,302 US participants in the Harris Interactive Chronic Illness Panel. Respondents reported behaviors related to cost-related medication non-adherence (CRN) and the impacts of medication costs on other aspects of their daily lives. Among respondents aged 40-64 and looking for work, 66% reported CRN in 2008, and 41% did not fill a prescription due to cost pressures. More than half of respondents aged 40-64 and nearly two-thirds of those in this group who were looking for work or disabled reported other impacts of medication costs, such as cutting back on basic needs or increasing credit card debt. More than one-third of respondents aged 65+ who were working or looking for work reported CRN. Regardless of age or employment status, roughly half of respondents reporting medication cost hardship said that these problems had become more frequent in 2008 than before the economic recession. These data show that many chronically ill patients, particularly those looking for work or disabled, reported greater medication cost problems since the economic crisis began. Given links between CRN and worse health, the financial downturn may have had significant health consequences for adults with chronic illness.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
United Kingdom 1 2%
Brazil 1 2%
Unknown 37 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 20%
Student > Master 5 12%
Student > Bachelor 5 12%
Student > Ph. D. Student 4 10%
Student > Postgraduate 3 7%
Other 8 20%
Unknown 8 20%
Readers by discipline Count As %
Medicine and Dentistry 9 22%
Social Sciences 8 20%
Nursing and Health Professions 4 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Psychology 3 7%
Other 6 15%
Unknown 8 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2015.
All research outputs
#8,534,976
of 25,374,647 outputs
Outputs from Patient preference and adherence
#639
of 1,757 outputs
Outputs of similar age
#44,881
of 120,716 outputs
Outputs of similar age from Patient preference and adherence
#4
of 6 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,757 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,716 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.